← Browse by Condition
Medical Condition
geographic atrophy secondary to age related macular degeneration
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06990269 Phase 2
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Enrollment
240 pts
Location
United States, Austr...
Sponsor
ADARx Pharmaceuticals, Inc.
NCT06662162
Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Enrollment
100 pts
Location
Australia, New Zeala...
Sponsor
i-Lumen Scientific AUS PTY LTD